Pharmacotherapy for post traumatic stress disorder (PTSD)
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Posttraumatic stress disorder (PTSD) is a prevalent and disabling disorder. Evidence that PTSD is characterised by specific psychobiological dysfunctions has contributed to a growing interest in the use of medication in its treatment. OBJECTIVES: To assess the effects of medication for reducing PTSD symptoms in adults with PTSD. SEARCH METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL; Issue 11, November 2020); MEDLINE (1946-), Embase (1974-), PsycINFO (1967-) and PTSDPubs (all available years) either directly or via the Cochrane Common Mental Disorders Controlled Trials Register (CCMDCTR). We also searched international trial registers. The date of the latest search was 13 November 2020. SELECTION CRITERIA: All randomised controlled trials (RCTs) of pharmacotherapy for adults with PTSD. DATA COLLECTION AND ANALYSIS: Three review authors (TW, JI, and NP) independently assessed RCTs for inclusion in the review, collated trial data, and assessed trial quality. We contacted investigators to obtain missing data. We stratified summary statistics by medication class, and by medication agent for all medications. We calculated dichotomous and continuous measures using a random-effects model, and assessed heterogeneity. MAIN RESULTS: We include 66 RCTs in the review (range: 13 days to 28 weeks; 7442 participants; age range 18 to 85 years) and 54 in the meta-analysis. For the primary outcome of treatment response, we found evidence of beneficial effect for selective serotonin reuptake inhibitors (SSRIs) compared with placebo (risk ratio (RR) 0.66, 95% confidence interval (CI) 0.59 to 0.74; 8 studies, 1078 participants), which improved PTSD symptoms in 58% of SSRI participants compared with 35% of placebo participants, based on moderate-certainty evidence. For this outcome we also found evidence of beneficial effect for the noradrenergic and specific serotonergic antidepressant (NaSSA) mirtazapine: (RR 0.45, 95% CI 0.22 to 0.94; 1 study, 26 participants) in 65% of people on mirtazapine compared with 22% of placebo participants, and for the tricyclic antidepressant (TCA) amitriptyline (RR 0.60, 95% CI 0.38 to 0.96; 1 study, 40 participants) in 50% of amitriptyline participants compared with 17% of placebo participants, which improved PTSD symptoms. These outcomes are based on low-certainty evidence. There was however no evidence of beneficial effect for the number of participants who improved with the antipsychotics (RR 0.51, 95% CI 0.16 to 1.67; 2 studies, 43 participants) compared to placebo, based on very low-certainty evidence. For the outcome of treatment withdrawal, we found evidence of a harm for the individual SSRI agents compared with placebo (RR 1.41, 95% CI 1.07 to 1.87; 14 studies, 2399 participants). Withdrawals were also higher for the separate SSRI paroxetine group compared to the placebo group (RR 1.55, 95% CI 1.05 to 2.29; 5 studies, 1101 participants). Nonetheless, the absolute proportion of individuals dropping out from treatment due to adverse events in the SSRI groups was low (9%), based on moderate-certainty evidence. For the rest of the medications compared to placebo, we did not find evidence of harm for individuals dropping out from treatment due to adverse events. AUTHORS' CONCLUSIONS: The findings of this review support the conclusion that SSRIs improve PTSD symptoms; they are first-line agents for the pharmacotherapy of PTSD, based on moderate-certainty evidence. The NaSSA mirtazapine and the TCA amitriptyline may also improve PTSD symptoms, but this is based on low-certainty evidence. In addition, we found no evidence of benefit for the number of participants who improved following treatment with the antipsychotic group compared to placebo, based on very low-certainty evidence. There remain important gaps in the evidence base, and a continued need for more effective agents in the management of PTSD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impact of Event Scale: A Measure of Subjective Stress
Horowitz, M., Wilner, N., & Alvarez, W. (1979) · Psychosomatic Medicine · doi:10.1097/00006842-197905000-00004 · Cited by 7,813
Meta-analyses involving cross-over trials: methodological issues
Elbourne, D. R., Altman, D. G., Higgins, J. P., Curtin, F., Worthington, H. V., & Vail, A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.140 · Cited by 2,305
Charney, D. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.195 · Cited by 1,605
Posttraumatic stress disorder in the world mental health surveys
Koenen, K. C., Ratanatharathorn, A., Ng, L., McLaughlin, K. A., Bromet, E. J., Stein, D. J., Karam, E. G., Meron Ruscio, A., Benjet, C., Scott, K., et al. (2017) · Psychological Medicine · doi:10.1017/s0033291717000708 · Cited by 1,453
Self-citationSheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
β-Adrenergic activation and memory for emotional events
Cahill, L., Prins, B., Weber, M., & McGaugh, J. L. (1994) · Nature · doi:10.1038/371702a0 · Cited by 1,271
Psychological debriefing for preventing post traumatic stress disorder (PTSD)
Rose, S. C., Bisson, J., Churchill, R., & Wessely, S. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000560 · Cited by 1,250
Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated
Thompson, S. G. (1994) · BMJ · doi:10.1136/bmj.309.6965.1351 · Cited by 1,017
Pilot study of secondary prevention of posttraumatic stress disorder with propranolol
Pitman, R. K., Sanders, K. M., Zusman, R. M., Healy, A. R., Cheema, F., Lasko, N. B., Cahill, L., & Orr, S. P. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01279-3 · Cited by 964
Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults
Bisson, J. I., Roberts, N. P., Andrew, M., Cooper, R., & Lewis, C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003388.pub4 · Cited by 829
Research works printed but not linked: 241
- Ahmadpanah, 2014, Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder, Neuropsychobiology, 69, 235-42, 10.1159/000362243 · DOI · Paper page
- Baker, 1995, A double-blind randomized placebo-controlled multi-center study of brofaromine in the treatment of post-traumatic stress disorder, Psychopharmacology, 122, 386, 10.1007/BF02246271 · DOI
- Connor, 2001, Predictors of treatment response in patients with posttraumatic stress disorder, Progress in Neuro-Psychopharmacology & Biological Psychiatry, 25, 337, 10.1016/S0278-5846(00)00163-9 · DOI
- Becker, 2007, A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder, Journal of Clinical Psychopharmacology, 27, 193, 10.1097/JCP.0b013e318032eaed · DOI · Paper page
- Brady, 2000, Efficacy and safety of sertraline treatment of posttraumatic stress disorder, Archives of General Psychiatry, 283, 1837
- Davidson, 2001, Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study, American Journal of Psychiatry, 158, 1974, 10.1176/appi.ajp.158.12.1974 · DOI · Paper page
- Davidson, 2002, Characterizing the effects of sertraline in post-traumatic stress disorder, Psychological Medicine, 32, 661, 10.1017/S0033291702005469 · DOI
- Gaffney, 2003, Factor analysis of treatment response in posttraumatic stress disorder, Journal of Traumatic Stress, 16, 77, 10.1023/A:1022067512964 · DOI
- Rapaport, 2002, Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment, Journal of Clinical Psychiatry, 63, 59, 10.4088/JCP.v63n0112 · DOI · Paper page
- Rapaport, 2000, Quality of life improvement in PTSD with sertraline treatment: results of a multicenter, placebo-controlled trial, International Journal of Neuropsychopharmacology, 3, 294
- Braun, 1990, Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment, Journal of Clinical Psychiatry, 51, 236
- Butterfield, 2001, Olanzapine in the treatment of post-traumatic stress disorder: a pilot study, International Clinical Psychopharmacology, 16, 197, 10.1097/00004850-200107000-00003 · DOI · Paper page
- Chung, 2004, Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial, Human Psychopharmacology, 19, 489-94, 10.1002/hup.615 · DOI
- Barnett, 2002, Tolerability of fluoxetine in posttraumatic stress disorder, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 26, 363, 10.1016/S0278-5846(01)00282-2 · DOI
- Connor, 1999, Fluoxetine in post-traumatic stress disorder: randomized, double-blind study, British Journal of Psychiatry, 175, 17, 10.1192/bjp.175.1.17 · DOI · Paper page
- Malik, 1999, Quality-of-life and posttraumatic stress disorder: a pilot study assessing changes in SF-36 scores before and after treatment in a placebo- controlled trial of fluoxetine, Journal of Traumatic Stress, 12, 387, 10.1023/A:1024745030140 · DOI · Paper page
- Connor, 2006, Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment, Psychopharmacology, 184, 21-5, 10.1007/s00213-005-0265-3 · DOI
- Davidson, 1990, Treatment of posttraumatic stress disorder with amitriptyline and placebo, Archives of General Psychiatry, 47, 259, 10.1001/archpsyc.1990.01810150059010 · DOI · Paper page
- Davidson, 1993, Predicting response to amitriptyline in posttraumatic stress disorder, American Journal of Psychiatry, 150, 1024, 10.1176/ajp.150.7.1024 · DOI · Paper page
- Davidson, 2000, Double-blind, randomized, 28-week continuation study of sertraline and placebo in posttraumatic stress disorder, International Journal of Neuropsychopharmacology, 3, 292
- Davidson, 2001, Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo controlled study, American Journal of Psychiatry, 158, 1974-81, 10.1176/appi.ajp.158.12.1974 · DOI · Paper page
- Davidson, 2002, Characterizing the effects of sertraline in post-traumatic stress disorder, Psychological Medicine, 32, 661, 10.1017/S0033291702005469 · DOI
- Davidson, 2001, Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder, Archives of General Psychiatry, 58, 485, 10.1001/archpsyc.58.5.485 · DOI · Paper page
- Rapaport, 2002, Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment, Journal of Clinical Psychiatry, 63, 59-65
- Davidson, 2000, Double-blind, randomized, 28-week continuation study of sertraline and placebo in posttraumatic stress disorder, International Journal of Neuropsychopharmacology, 3, 292
- Davidson, 2001, Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study, American Journal of Psychiatry, 158, 1974, 10.1176/appi.ajp.158.12.1974 · DOI · Paper page
- Rapaport, 2002, Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment, Journal of Clinical Psychiatry, 63, 59, 10.4088/JCP.v63n0112 · DOI · Paper page
- Davidson, 2003, Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial, Biological Psychiatry, 53, 188, 10.1016/S0006-3223(02)01411-7 · DOI · Paper page
- Davidson, 2005, Maintenance therapy with fluoxetine in posttraumatic stress disorder: a placebo-controlled discontinuation study, Journal of Clinical Psychopharmacology, 25, 166-9, 10.1097/01.jcp.0000155817.21467.6c · DOI · Paper page
- Davidson, 2006, Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial, Archives of General Psychiatry, 63, 1158, 10.1001/archpsyc.63.10.1158 · DOI · Paper page
- Davidson, 2006, Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study, Journal of Clinical Psychopharmacology, 26, 259, 10.1097/01.jcp.0000222514.71390.c1 · DOI · Paper page
- Davidson, 2007, The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder, Journal of Clinical Psychopharmacology, 27, 85-8, 10.1097/JCP.0b013e31802e5115 · DOI · Paper page
- Davis, 2004, A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study, Journal of Clinical Psychopharmacology, 24, 291, 10.1097/01.jcp.0000125685.82219.1a · DOI · Paper page
- Davis, 2008, Divalproex in the treatment of posttraumatic tress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population, Journal of Clinical Psychopharmacology, 28, 84-8, 10.1097/jcp.0b013e318160f83b · DOI · Paper page
- Davis, 2020, A randomized, placebo-controlled trial of mirtazapine for the treatment of posttraumatic stress disorder in v eterans, Journal of Clinical Psychiatry, 81, e1, 10.4088/JCP.20m13267 · DOI
- Friedman, 2007, Randomised, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting, Journal of Clinical Psychiatry, 68, 711, 10.4088/JCP.v68n0508 · DOI · Paper page
- Hamner, 2008, A preliminary controlled trial of divalproex in posttraumatic stress disorder, Annals of Clinical Psychiatry, 21, 89
- Hertzberg, 1999, A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder, Biological Psychiatry, 45, 1226, 10.1016/S0006-3223(99)00011-6 · DOI · Paper page
- Hertzberg, 2000, Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans, Annals of Clinical Psychiatry, 12, 101, 10.3109/10401230009147096 · DOI · Paper page
- Kaplan, 1996, Inositol treatment of posttraumatic stress disorder, Anxiety, 2, 51-2, 10.1002/(SICI)1522-7154(1996)2:1<51::AID-ANXI8>3.0.CO;2-G · DOI
- Connor, 2001, Predictors of treatment response in patients with posttraumatic stress disorder, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 25, 337-45, 10.1016/S0278-5846(00)00163-9 · DOI
- Katz, 1994, Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic, Anxiety, 1, 169-74, 10.1002/anxi.3070010404 · DOI
- Kosten, 1991, Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine, Journal of Nervous and Mental Disease, 179, 366-70, 10.1097/00005053-199106000-00011 · DOI · Paper page
- Li, 2017, Effect and safety of sertraline for treat posttraumatic stress disorder: a multicenter randomised controlled study, International Journal of Psychiatry in Clinical Practice, 21, 151, 10.1080/13651501.2017.1291838 · DOI
- Marshall, 2001, Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study, American Journal of Psychiatry, 158, 1982, 10.1176/appi.ajp.158.12.1982 · DOI · Paper page
- Marshall R Blanco C Lewis-Fernandez R Simpson B Lin SH Garcia W Randomized controlled trial of paroxetine in adults with chronic PTSD 18th Annual Meeting, International Society for Traumatic Stress Studies, November 7 - 10, Baltimore, MD 2002 · DOI
- Martenyi, 2002, Fluoxetine versus placebo in posttraumatic stress disorder, Journal of Clinical Psychiatry, 63, 199, 10.4088/JCP.v63n0305 · DOI · Paper page
- Martenyi, 2002, Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder, British Journal of Psychiatry, 181, 315, 10.1192/bjp.181.4.315 · DOI · Paper page
- Martenyi, 2007, Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study, Journal of Clinical Psychopharmacology, 27, 166-70, 10.1097/JCP.0b013e31803308ce · DOI · Paper page
- Mathew, 2011, A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial, European Neuropsychopharmacology, 21, 221-9, 10.1016/j.euroneuro.2010.11.012 · DOI · Paper page
- McCall, 2018, A randomized controlled trial (RCT) of prazosin versus placebo for suicidal posttraumatic stress disorder (PTSD) patients with nightmares-a pilot study, Sleep, 41, A351, 10.1097/JCP.0000000000000968 · DOI
- McRae, 2004, Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder, Depression and Anxiety, 19, 190-6, 10.1002/da.20008 · DOI · Paper page
- Padala, 2006, Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women, International Clinical Psychopharmacology, 21, 275-80, 10.1097/00004850-200609000-00005 · DOI
- Panahi, 2011, A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder, Psychological Medicine, 41, 2159-66, 10.1017/S0033291711000201 · DOI · Paper page
- Friedman, 2007, Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting, Journal of Clinical Psychiatry, 68, 711, 10.4088/JCP.v68n0508 · DOI · Paper page
- Rasmusson, 2017, A randomized controlled trial of ganaxolone in posttraumatic stress disorder, Psychopharmacology, 234, 2245-57, 10.1007/s00213-017-4649-y · DOI
- Reich, 2004, A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women, Journal of Clinical Psychiatry, 65, 1601, 10.4088/JCP.v65n1204 · DOI · Paper page
- Reist, 1995, REM latency, dexamethasone suppression test, and thyroid releasing hormone stimulation test in posttraumatic stress disorder, Progress in Neuropsychopharmacology and Biological Psychiatry, 19, 433, 10.1016/0278-5846(95)00024-P · DOI
- Reist, 1989, A controlled trial of desipramine in 18 men with posttraumatic stress disorder, American Journal of Psychiatry, 146, 513, 10.1176/ajp.146.4.513 · DOI · Paper page
- Saygin, 2002, Nefazodone versus sertraline in treatment of posttraumatic stress disorder, Bulletin of Clinical Psychopharmacology, 12, 1
- Shestatzky, 1988, A controlled trial of phenelzine in posttraumatic stress disorder, Psychiatric Research, 24, 149, 10.1016/0165-1781(88)90057-1 · DOI · Paper page
- Stein, 2003, Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studies, Expert Opinion on Pharmacotherapy, 4, 1829, 10.1517/14656566.4.10.1829 · DOI · Paper page
- Spivak, 2006, Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial, Journal of Clinical Psychopharmacology, 26, 152-6, 10.1097/01.jcp.0000203195.65710.f0 · DOI · Paper page
- Tucker, 2001, Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial, Journal of Clinical Psychiatry, 62, 860, 10.4088/JCP.v62n1105 · DOI · Paper page
- Tucker, 2003, Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo, General Psychopharmacology, 37, 135
- Tucker, 2007, Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study, Journal of Clinical Psychiatry, 68, 201, 10.4088/JCP.v68n0204 · DOI
- Van der Kolk, 1994, Fluoxetine treatment in posttraumatic stress disorder, Journal of Clinical Psychiatry, 55, 517
- Van der Kolk, 2007, A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance, Journal of Clinical Psychiatry, 68, 37, 10.4088/JCP.v68n0105 · DOI · Paper page
- Villarreal, 2016, Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial, American Journal of Psychiatry, 173, 1205, 10.1176/appi.ajp.2016.15070967 · DOI · Paper page
- Yeh, 2011, A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD, CNS Neuroscience and Therapeutics, 17, 305-10, 10.1111/j.1755-5949.2010.00188.x · DOI · Paper page
- Amital, 2000, A placebo-controlled study of sertraline in posttraumatic stress disorder, International Journal of Neuropsychopharmacology, 3, 269
- Zohar, 2002, Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder, Journal of Clinical Psychopharmacology, 22, 190, 10.1097/00004714-200204000-00013 · DOI · Paper page
- Aerni, 2004, Low-dose cortisol for symptoms of posttraumatic stress disorder, American Journal of Psychiatry, 161, 1488, 10.1176/appi.ajp.161.8.1488 · DOI · Paper page
- Angelidis, 2019, P.3.26 Effects of hydrocortisone on cognitive performance and threat-interference under acute stress in highly anxious females, European Neuropsychopharmacology, 29, S698, 10.1016/j.euroneuro.2019.01.088 · DOI
- Back, 2016, A double-blind, randomized, controlled pilot trial of N-Acetylcysteine in veterans with posttraumatic stress disorder and substance use disorders, Journal of Clinical Psychiatry, 77, e1439, 10.4088/JCP.15m10239 · DOI · Paper page
- Back, 2018, Doxazosin for the treatment of co-occurring PTSD and alcohol use disorder: design and methodology of a randomized controlled trial in military veterans, Contemporary Clinical Trials, 73, 8, 10.1016/j.cct.2018.08.009 · DOI
- Bartzokis, 2005, Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder, Biological Psychiatry, 57, 474, 10.1016/j.biopsych.2004.11.039 · DOI · Paper page
- Batki, 2014, Topiramate treatment of alcohol use disorder in veterans with PTSD: a randomized controlled pilot trial, Alcoholism: Clinical and Experimental Research, 38, 2169-77, 10.1111/acer.12496 · DOI · Paper page
- Boroughs, 2018, Posttraumatic stress symptoms and emerging adult sexual minority men: implications for assessment and treatment of childhood sexual abuse, Journal of Traumatic Stress, 31, 665, 10.1002/jts.22335 · DOI
- Starr, 2019, Prospective study of the effectiveness of paroxetine on the onset of posttraumatic stress disorder, depression, and health and functional outcomes after trauma, Journal of Orthopaedic Trauma, 33, e58, 10.1097/BOT.0000000000001342 · DOI
- Bountress, 2018, Treatment of co-occurring posttraumatic stress disorder and substance use: does order of onset influence outcomes?, Psychological Trauma: Theory, Research, Practice and Policy, 10, 662, 10.1037/tra0000309 · DOI
- Brady, 2005, Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder, Alcoholism: Clinical and Experimental Research, 29, 395-401, 10.1097/01.ALC.0000156129.98265.57 · DOI
- Bremner, 1997, Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder, Archives of General Psychiatry, 54, 246, 10.1001/archpsyc.1997.01830150070011 · DOI · Paper page
- Brunet, 2018, Reduction of PTSD symptoms with pre-reactivation propranolol therapy: a randomized controlled trial, American Journal of Psychiatry, 175, 427, 10.1176/appi.ajp.2017.17050481 · DOI · Paper page
- Buhmann, 2018, Long-term treatment effect of trauma-affected refugees with flexible cognitive behavioural therapy and antidepressants, Psychiatry Research, 264, 217, 10.1016/j.psychres.2018.03.069 · DOI
- Coupland, 1997, A pilot controlled study of the effects of flumazenil in posttraumatic stress disorder, Biological Psychiatry, 41, 988, 10.1016/S0006-3223(97)00043-7 · DOI
- Flanagan, 2018, Effects of oxytocin on working memory and executive control system connectivity in posttraumatic stress disorder, Experimental and Clinical Psychopharmacology, 26, 391, 10.1037/pha0000197 · DOI
- Flanagan, 2019, Effects of oxytocin on stress reactivity and craving in veterans with co-occurring PTSD and alcohol use disorder, Experimental and Clinical Psychopharmacology, 27, 45, 10.1037/pha0000232 · DOI
- Frank, 1988, A randomized clinical trial of phenelzine and imipramine for post-traumatic stress disorder, American Journal of Psychiatry, 145, 1289, 10.1176/ajp.145.10.1289 · DOI · Paper page
- Frijling, 2017, Preventing PTSD with oxytocin: effects of oxytocin administration on fear neurocircuitry and PTSD symptom development in recently trauma-exposed individuals, European Journal of Psychotraumatology, 8, 1302652, 10.1080/20008198.2017.1302652 · DOI
- Gelpin, 1996, Treatment of recent trauma survivors with benzodiazepines: a prospective study, Journal of Clinical Psychiatry, 57, 390
- Graham, 2018, High expectancy and early response produce optimal effects in sertraline treatment for post-traumatic stress disorder, British Journal of Psychiatry, 213, 704, 10.1192/bjp.2018.211 · DOI
- Hamner, 1997, Buspirone potentiation of antidepressants in the treatment of PTSD, Depression and Anxiety, 5, 137, 10.1002/(SICI)1520-6394(1997)5:3<137::AID-DA6>3.0.CO;2-B · doi:10.1002/(sici)1520-6394(1997)5:3<137::aid-da6>3.0.co;2-b
- Hamner, 1999, Procaine administration and behavioral responsivity in post-traumatic stress disorder: a pilot study of tolerability, Human Psychopharmacology, 14, 105, 10.1002/(SICI)1099-1077(199903)14:2<105::AID-HUP75>3.0.CO;2-E · doi:10.1002/(sici)1099-1077(199903)14:2<105::aid-hup75>3.0.co;2-e
- Hamner, 2003, Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms, International Clinical Psychopharmacology, 18, 1
- Inslicht, 2018, Randomized controlled trial of hydrocortisone and D-cycloserine on fear extinction in PTSD, Biological Psychiatry, 83, S352, 10.1016/j.biopsych.2018.02.905 · DOI
- Jacobs-Rebhun, 2000, Posttraumatic stress disorder and sleep difficulty, American Journal of Psychiatry, 157, 1525, 10.1176/appi.ajp.157.9.1525 · DOI
- Kanter, 2001, Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorder, Biological Psychiatry, 50, 238, 10.1016/S0006-3223(01)01158-1 · DOI
- Kellner, 2000, Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder, Biological Psychiatry, 47, 107, 10.1016/S0006-3223(99)00118-3 · DOI
- Le, 2018, Effects of treatment, choice, and preference on health-related quality-of-life outcomes in patients with posttraumatic stress disorder (PTSD), Quality of Life Research, 27, 1555, 10.1007/s11136-018-1833-4 · DOI
- Mello, 2009, A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder, BMC Psychiatry, 9, 1, 10.1186/1471-244X-9-28 · DOI
- Monnelly, 2003, Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder, Journal of Clinical Psychopharmacology, 23, 193, 10.1097/00004714-200304000-00012 · DOI · Paper page
- Grillon, 1995, Yohimbine facilitated acoustic startle in combat veterans with post-traumatic stress disorder, Psychopharmacology, 117, 466, 10.1007/BF02246220 · DOI
- Naylor, 2013, A pilot randomized controlled trial with paroxetine for subthreshold PTSD in operation enduring freedom/operation Iraqi freedom era veterans, Psychiatry Research Journal, 206, 318-20, 10.1016/j.psychres.2012.11.008 · DOI
- Neylan, 2006, No improvement of posttraumatic stress disorder symptoms with guanfacine treatment, American Journal of Psychiatry, 163, 2186-8, 10.1176/ajp.2006.163.12.2186 · DOI · Paper page
- Pape, 2018, DNA methylation levels are associated with CRF1 receptor antagonist treatment outcome in women with post-traumatic stress disorder, Clinical Epigenetics, 10, 136, 10.1186/s13148-018-0569-x · DOI
- Petrakis, 2006, Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder, Biological Psychiatry, 60, 777, 10.1016/j.biopsych.2006.03.074 · DOI
- Pollack, 2011, Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial, Journal of Clinical Psychiatry, 72, 892, 10.4088/JCP.09m05607gry · DOI · Paper page
- Ramaswamy, 2016, Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder, Contemporary Clinical Trials Communications, 2, 1, 10.1016/j.conctc.2015.12.003 · DOI
- Randall, 1995, Effects of the benzodiazepine antagonist flumazenil in PTSD, Biological Psychiatry, 38, 319, 10.1016/0006-3223(94)00306-N · DOI · Paper page
- Raskind, 2003, Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study, American Journal of Psychiatry, 160, 371, 10.1176/appi.ajp.160.2.371 · DOI · Paper page
- Raskind, 2007, A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder, Society of Biological Psychiatry, 61, 928-34, 10.1016/j.biopsych.2006.06.032 · DOI · Paper page
- Raskind, 2013, A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan, American Journal of Psychiatry, 170, 1003, 10.1176/appi.ajp.2013.12081133 · DOI · Paper page
- Reist, 1995, REM latency, dexamethasone suppression test, and thyroid releasing hormone stimulation test in posttraumatic stress disorder, Progress in Neuropsychopharmacology and Biological Psychiatry, 19, 433, 10.1016/0278-5846(95)00024-P · DOI
- Reist, 2001, Beta-adrenergic blockade and emotional memory in PTSD, International Journal of Neuropsychopharmacology, 4, 377, 10.1017/S1461145701002607 · DOI · Paper page
- Schelling, 2004, Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized study, Biological Psychiatry, 55, 627, 10.1016/j.biopsych.2003.09.014 · DOI · Paper page
- Southwick, 1997, Noradrenergic and serotonergic function in posttraumatic stress disorder, Archives of General Psychiatry, 54, 749, 10.1001/archpsyc.1997.01830200083012 · DOI · Paper page
- Stein, 2002, Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study, American Journal of Psychiatry, 159, 1777, 10.1176/appi.ajp.159.10.1777 · DOI · Paper page
- Suris, 2017, Facilitating fear-based memory extinction with dexamethasone: a randomized controlled trial in male veterans with combat-related PTSD, Psychiatry, 80, 399, 10.1080/00332747.2017.1286892 · DOI
- Van der Kolk, 1989, Endogenous opioids, stress induced analgesia, and posttraumatic stress disorder, Psychopharmacology Bulletin, 25, 417
- Verplaetse, 2019, Alcohol abstainer status and prazosin treatment in association with changes in posttraumatic stress disorder symptoms in veterans with comorbid alcohol use disorder and posttraumatic stress disorder, Alcoholism: Clinical and Experimental Research, 43, 741, 10.1111/acer.13969 · DOI
- Albucher, 2002, Psychopharmacological treatment in PTSD: a critical review, Journal of Psychiatric Research, 36, 355, 10.1016/S0022-3956(02)00058-4 · DOI
- Amos, 2014, Pharmacological interventions for preventing post-traumatic stress disorder (PTSD), Cochrane Database of Systematic Reviews, 10.1002/14651858.CD006239.pub2 · DOI · Paper page
- American Psychiatric Association, 1980, Diagnostic and statistical manual of mental disorders (DSM-III)
- American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders (DSM-IV)
- American Psychiatric Association, 2013, Diagnostic and statistical manual of mental Disorders, fifth edition, 10.1176/appi.books.9780890425596 · DOI · Paper page
- Asnis, 2004, SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations, Drugs, 64, 383, 10.2165/00003495-200464040-00004 · DOI · Paper page
- 1999, The promise and problems of meta-analysis, New England Journal of Medicine, 337, 559
- Baker, 2003, Quantitative analysis of sponsorship bias in economic studies of antidepressants, British Journal of Psychiatry, 183, 498, 10.1192/03-2 · DOI · Paper page
- Ballenger, 2000, Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety, Journal of Clinical Psychiatry, 61, 60
- Ballenger, 2004, Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety, Journal of Clinical Psychiatry, 65, 55
- Bandelow, 2008, World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-raumatic tress disorders -first revision, World Journal of Biological Psychiatry, 9, 248, 10.1080/15622970802465807 · DOI · Paper page
- Basoglu, 1992, Amitriptyline for PTSD in a torture survivor: a case study, Journal of Traumatic Stress, 5, 77, 10.1007/BF00976812 · DOI
- Beck, 1961, An inventory for measuring depression, Archives of General Psychiatry, 4, 561, 10.1001/archpsyc.1961.01710120031004 · DOI · Paper page
- Bernardy, 2017, Pharmacological management of posttraumatic stress disorder, Current Opinion in Psychology, 14, 116, 10.1016/j.copsyc.2017.01.003 · DOI
- Blake, 1990, A clinician rating scale for assessing current and lifetime PTSD: The CAPS-1, Behavior Therapy, 21, 187
- Bleich, 1986, Post-traumatic stress disorder following combat exposure: clinical features and psychopharmacological treatment, British Journal of Psychiatry, 149, 365, 10.1192/bjp.149.3.365 · DOI · Paper page
- Bradley, 2005, A multidimensional meta-analysis of psychotherapy for PTSD, American Journal of Psychiatry, 162, 214, 10.1176/appi.ajp.162.2.214 · DOI · Paper page
- Bremner, 2004, Neuroanatomical changes associated with pharmacotherapy in posttraumatic stress disorder, Annals of the New York Academy of Science, 1032, 154, 10.1196/annals.1314.012 · DOI
- Breslau, 1991, Traumatic events and post traumatic stress disorder in an urban population of young adults, Archives of General Psychiatry, 48, 216, 10.1001/archpsyc.1991.01810270028003 · DOI · Paper page
- Brom, 1989, Brief psychotherapy for posttraumatic stress disorders, Journal of Consulting and Clinical Psychology, 57, 607, 10.1037/0022-006X.57.5.607 · doi:10.1037/0022-006x.57.5.607 · Paper page
- Brophy, 1991, Cyproheptadine for combat nightmares in post-traumatic stress disorder and dream anxiety disorder, Military Medicine, 156, 100, 10.1093/milmed/156.2.100 · DOI
- Brunello, 2001, Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment, Neuropsychobiology, 43, 150, 10.1159/000054884 · DOI · Paper page
- Burstein, 1984, Treatment of posttraumatic stress disorder with imipramine, Psychosomatics, 25, 681, 10.1016/S0033-3182(84)72977-X · DOI
- Burton, 1999, Categorizing fear: the role of trauma in a clinical formulation, American Journal of Psychiatry, 156, 761, 10.1176/ajp.156.5.761 · DOI
- Canive, 1997, MRI reveals gross structural abnormalities in PTSD, Annals of the New York Academy of Sciences, 821, 512, 10.1111/j.1749-6632.1997.tb48318.x · DOI
- Canive, 1998, Bupropion treatment in veterans with posttraumatic stress disorder: an open study, Journal of Clinical Psychopharmacology, 18, 379, 10.1097/00004714-199810000-00005 · DOI
- Charney, 1993, Psychobiologic mechanisms of posttraumatic stress disorder, Archives of General Psychiatry, 50, 294, 10.1001/archpsyc.1993.01820160064008 · DOI · Paper page
- Chen, 1991, The obsessive quality and clomipramine treatment of PTSD, American Journal of Psychiatry, 148, 1087, 10.1176/ajp.148.8.1087 · DOI
- Connor, 1998, The role of serotonin in posttraumatic stress disorder: neurobiology and pharmacotherapy, CNS Spectrums, 3, 43
- Connor, 1999, A pilot study of mirtazapine in post-traumatic stress disorder, International Clinical Psychopharmacology, 14, 29, 10.1097/00004850-199901000-00003 · DOI · Paper page
- Covi, 1984, Primary depression or primary anxiety: a possible psychometric approach to a diagnostic dilemma, Clinical Neuropharmacology, 7, S502, 10.1097/00002826-198406001-00458 · DOI
- Creamer, 2003, Psychometric properties of the Impact of Event Scale-Revised, Behaviour Research and Therapy, 41, 1489-96, 10.1016/j.brat.2003.07.010 · DOI · Paper page
- Cyr, 2000, Treatment for posttraumatic stress disorder, Annals of Pharmacotherapy, 34, 366, 10.1345/aph.19120 · doi:10.1345/aph.19120 · Paper page
- Davidson, 1987, A pilot study of phenelzine in the treatment of post-traumatic stress disorder, British Journal of Psychiatry, 150, 252, 10.1192/bjp.150.2.252 · DOI
- Davidson, 1989, Pharmacotherapy in posttraumatic stress disorder: historical and clinical considerations and future directions, Psychopharmacology Bulletin, 25, 422
- Davidson, 1993, Predicting response to amitriptyline in posttraumatic stress disorder, American Journal of Psychiatry, 150, 1024, 10.1176/ajp.150.7.1024 · DOI · Paper page
- Davidson, 1997, Response characteristics to antidepressants and placebo in post-traumatic stress disorder, International Clinical Psychopharmacology, 12, 291, 10.1097/00004850-199711000-00001 · DOI · Paper page
- Davidson, 1997, Biological therapies for posttraumatic stress disorder: an overview, Journal of Clinical Psychiatry, 58, 33
- Davidson, 1997, Assessment of a new self-rating scale for posttraumatic stress disorder, Psychological Medicine, 27, 153, 10.1017/S0033291796004229 · DOI · Paper page
- Davidson, 1998, Fluvoxamine in civilians with posttraumatic stress disorder, Journal of Clinical Psychopharmacology, 18, 93, 10.1097/00004714-199802000-00020 · DOI · Paper page
- Davidson, 2000, Pharmacotherapy of posttraumatic stress disorder: treatment options, long term follow-up, and predictors of outcome, Journal of Clinical Psychiatry, 61, 52
- Davis, 2000, Nefazodone treatment for chronic posttraumatic stress disorder: an open trial, Journal of Clinical Psychopharmacology, 20, 159, 10.1097/00004714-200004000-00007 · DOI · Paper page
- Deeks, 2001, Systematic Reviews in Health Care: Meta-Analysis in Context
- Deeks, 2003, The Cochrane Library
- Deeks, 2008, Egger M, Davey SG, Altman DG editor(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd Edition, 285-12
- De Jong, 2001, Lifetime events and posttraumatic stress disorder in 4 postconflict settings, JAMA, 286, 555, 10.1001/jama.286.5.555 · DOI · Paper page
- Dillard, 1993, Use of thioridazine in post-traumatic stress disorder, Southern Medical Journal, 86, 1276, 10.1097/00007611-199311000-00022 · DOI
- Dow, 1997, Antidepressant treatment of posttraumatic stress disorder and major depression in veterans, Annals of Clinical Psychiatry, 9, 1, 10.3109/10401239709147767 · doi:10.3109/10401239709147767
- Duffy, 1992, Rapid response to buspirone in a case of post-traumatic stress disorder, Annals of Clinical Psychiatry, 4, 193, 10.3109/10401239209149571 · DOI
- Duffy, 1994, Efficacy of buspirone in the treatment of posttraumatic stress disorder: An open trial, Annals of Clinical Psychiatry, 6, 33, 10.3109/10401239409148837 · DOI · Paper page
- Falcon, 1985, Tricyclics: possible treatment for post-traumatic stress disorder, Journal of Clinical Psychiatry, 46, 385
- Famularo, 1988, Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study, American Journal of Diseases of Children, 142, 1244, 10.1001/archpedi.1988.02150110122036 · DOI · Paper page
- Fesler, 1991, Valproate in combat-related posttraumatic stress disorder, Journal of Clinical Psychiatry, 52, 361
- Fichtner, 1990, Decreased episodic violence and increased control of dissociation in a carbamazepine-treated case of multiple personality, Biological Psychiatry, 27, 1045, 10.1016/0006-3223(90)90040-9 · DOI
- Fichtner, 1994, Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress disorder: preliminary observations on a possible predictor of clinical treatment response, Life Sciences, 54, 39, 10.1016/0024-3205(94)00592-3 · DOI
- Foa, 1999, The expert consensus guideline series: treatment of posttraumatic stress disorder: the expert consensus panel for PTSD, Journal of Clinical Psychiatry, 60, 1
- Ford, 1996, The use of anticonvulsants in posttraumatic stress disorder: case study and overview, Journal of Traumatic Stress, 9, 857, 10.1002/jts.2490090413 · doi:10.1002/jts.2490090413
- Forster, 1994, Lithium for irritability in post-traumatic stress disorder, Journal of Traumatic Stress, 8, 143, 10.1002/jts.2490080110 · doi:10.1002/jts.2490080110
- Franco, 2016, Generalizability of pharmacologic and psychotherapy clinical trial results for posttraumatic stress disorder to community samples, Journal of Clinical Psychiatry, 77, 975, 10.4088/JCP.15m10060 · DOI · Paper page
- Gersons, 2000, Randomized clinical trial of brief eclectic psychotherapy for police officers with posttraumatic stress disorder, Journal of Trauma Stress, 13, 333, 10.1023/A:1007793803627 · DOI · Paper page
- Gilboa-Schechtman, 2010, Prolonged exposure versus dynamic therapy for adolescent PTSD: a pilot randomized controlled trial, Journal of the American Academy of Child and Adolescent Psychiatry, 49, 1034, 10.1016/j.jaac.2010.07.014 · DOI · Paper page
- Gist, 2015, Encyclopaedia of Clinical Psychology
- Glover, 1993, A preliminary trial of nalmefene for the treatment of emotional numbing in combat veterans with post-traumatic stress disorder, Israel Journal of Psychiatry and Related Sciences, 30, 255
- Gupta, 1998, Efficacy of cyproheptadine for nightmares associated with posttraumatic stress disorder, Comprehensive Psychiatry, 39, 160, 10.1016/S0010-440X(98)90076-1 · DOI
- Gury, 1999, Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability, Encephale, 25, 470
- Guy, 1976, ECDEU assessment manual for psychopharmacology
- Hamilton, 1959, The assessment of anxiety states by rating, British Journal of Medical Psychology, 32, 50, 10.1111/j.2044-8341.1959.tb00467.x · DOI · Paper page
- Hamilton, 1960, A rating scale for depression, Journal of Neurology, Neurosurgery & Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
- Hamner, 1996, Clozapine treatment for a veteran with comorbid psychosis and PTSD (letter), American Journal of Psychiatry, 153, 841, 10.1176/ajp.153.6.841 · DOI
- Hamner, 1998, Response to venlafaxine in a previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder, International Clinical Psychopharmacology, 13, 233, 10.1097/00004850-199809000-00008 · DOI
- Harmon, 1996, Clonidine for posttraumatic stress disorder in preschool children, Journal of the American Academy of Child & Adolescent Psychiatry, 35, 1247, 10.1097/00004583-199609000-00022 · DOI · Paper page
- Hertzberg, 1996, Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design, Journal of Clinical Psychopharmacology, 16, 294, 10.1097/00004714-199608000-00004 · DOI
- Hertzberg, 1998, Open trial of nefazodone for combat-related posttraumatic stress disorder, Journal of Clinical Psychiatry, 59, 460, 10.4088/JCP.v59n0904 · DOI · Paper page
- Hidalgo, 1999, Nefazodone in posttraumatic stress: results from six open-label trials, International Clinical Psychopharmacology, 14, 61, 10.1097/00004850-199903000-00001 · DOI · Paper page
- Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
- Hogben, 1981, Treatment of traumatic war neurosis with phenelzine, Archives of General Psychiatry, 38, 440, 10.1001/archpsyc.1981.01780290074008 · DOI · Paper page
- Horrigan, 1996, Guanfacine for PTSD nightmares, Journal of the American Academy of Child & Adolescent Psychiatry, 35, 975, 10.1097/00004583-199608000-00006 · DOI
- Irwin, 1989, Pharmacologic treatment of veterans with posttraumatic stress disorder and concomitant affective disorder, Annals of Clinical Psychiatry, 1, 127, 10.3109/10401238909149968 · DOI
- Izrayelit, 1998, Schizoaffective disorder and PTSD successfully treated with olanzapine and supportive psychotherapy, Psychiatric Annals, 28, 424, 10.3928/0048-5713-19980801-04 · DOI
200 of 241 shown
Cited by
Brubaker, M., Kapadia, S., Maletic, V., Chambers, J., Watling, C., & Citrome, L. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s501207 · Cited by 7
BNC210, an α7 Nicotinic Receptor Modulator, in Post-Traumatic Stress Disorder
Papapetropoulos, S., Doolin, E., O’Connor, S., Paul, D., Odontiadis, M., Jaros, M., Rolan, P., & Stein, M. B. (2025) · NEJM Evidence · doi:10.1056/evidoa2400380 · Cited by 5
Mak, B. S. W., Zhang, D., Powell, C. L. Y. M., Leung, M. K. W., Lo, H. H. M., Yang, X., Yip, B. H. K., Lee, E. K. P., Xu, Z., & Wong, S. Y. S. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05840-x · Cited by 2
Systematic review on the treatment of emotional abuse victimization in women by an intimate partner
Karakurt, G., Koc, E., D’Silva, R., Oğuztüzün, Ç., Choudhary, A., Goto, T., Gao, K., & Bolen, S. (2025) · Journal of Family Violence · doi:10.1007/s10896-025-00891-4 · Cited by 2
Metadata
- Authors
- Williams, T., Phillips, N. J., Stein, D. J., & Ipser, J. C.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2022-03-02
- Volume
- 2022
- Issue
- 3
- Pages
- CD002795-CD002795
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W4214870542
- Cited by
- 73
- References
- 36
- FWCI
- 12.65
- Type
- journal article
- Language
- en
- Update notices
- new_version (2026-05-28)
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacotherapy for post traumatic stress disorder (PTSD). https://app.cochat.ai/papers/10.1002/14651858.cd002795.pub3
- The paper
- Williams, T., Phillips, N. J., Stein, D. J., & Ipser, J. C. (2022). Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd002795.pub3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.